Digital Therapeutics & Prescription Apps
Software is becoming the new medicine. These carefully selected companies are developing FDA-cleared applications that treat everything from mental health to diabetes. With growing insurance reimbursement and massive scalability, these digital treatments represent healthcare's next frontier.
Your Basket's Financial Footprint
Summary of total market capitalisation and constituent breakdown for the Digital Therapeutics & Prescription Apps basket.
- Large-cap dominance implies generally lower volatility and more stable, market-tracking performance compared with smaller-cap-focused baskets.
- Suitable as a core holding: adds broad sector exposure, not recommended as a speculative, short-term trade.
- Expect steady, long-term value; unlikely to deliver rapid, explosive short-term gains.
DRIO: $51.25M
GDRX: $1.35B
TDOC: $1.53B
- Other
About This Group of Stocks
Our Expert Thinking
Digital therapeutics represent a fundamental shift in healthcare delivery. These clinically-validated software programs are designed to prevent, manage, or treat medical conditions without traditional drugs or devices. As healthcare embraces technology, these scalable solutions promise better patient outcomes at lower costs.
What You Need to Know
This is an emerging, high-growth sector with significant potential but also substantial risk. Insurance reimbursement is the critical catalyst for widespread adoption. Companies range from pure-play digital therapeutics developers to larger telehealth platforms incorporating these technologies into broader offerings.
Why These Stocks
We've selected companies directly involved in creating or delivering software-based medical treatments. This includes dedicated digital therapeutics developers, telehealth platforms enabling digital prescriptions, and companies creating complementary technologies that support this emerging ecosystem.
Why You'll Want to Watch These Stocks
Software Is Becoming Medicine
These companies are creating FDA-cleared apps that actually treat diseases. It's a whole new category of medicine where code itself becomes the treatment—potentially reaching millions of patients at a fraction of traditional costs.
Insurance Companies Are Paying Up
The big breakthrough? Insurance providers are increasingly willing to reimburse for these digital therapies. This payment validation could trigger explosive growth as these treatments become mainstream healthcare options.
Early Days of a Healthcare Revolution
We're just at the beginning of software-as-medicine. With chronic diseases, mental health conditions, and preventative care all being targeted, these companies are pioneering what could become a multi-billion dollar healthcare category.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Payroll Stocks: Could Gig Worker Rulings Drive New Demand?
A recent New Zealand Supreme Court ruling reclassified Uber drivers as employees, setting a major precedent for the global gig economy. This shift creates a potential investment opportunity in companies that provide essential payroll, benefits, and HR management services, which will be in higher demand as gig workers gain employment status.
Global Infrastructure Partners: UAE Exposure Risks
The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.
UAE Infrastructure Global Suppliers Breakdown
As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.